Return to homepagePandemic Pact

CAMOVID: Multicenter, randomized 1: 1, double-blind, placebo-controlled two-arm trial to evaluate the efficacy and safety of camostat mesylate for the treatment of SARS-CoV-2 infection in adult ambulatory patients (trial CAMOVID)

  • Funded by Ministre des Solidarités et de la Santé (France)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Ministre des Solidarités et de la Santé (France)

  • Principal Investigator

    David Boutboul

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract